Effect of recombinant bovine basic fibroblast growth factor on cataract patients with low endothelial cell density after phacoemulsification and intraocular lens implantation
10.3980/j.issn.1672-5123.2025.12.19
- VernacularTitle:角膜内皮细胞低下白内障患者超声乳化人工晶状体植入术后应用re-bFGF效果
- Author:
Xing FANG
1
;
Man LI
1
;
Qinman LI
1
Author Information
1. Department of Ophthalmology, Guangyuan Central Hospital, Guangyuan 628000, Sichuan Province, China
- Publication Type:Journal Article
- Keywords:
recombinant bovine basic fibroblast growth factor(re-bFGF);
cataract;
endothelial cell density;
phacoemulsification;
postoperative complications
- From:
International Eye Science
2025;25(12):1999-2004
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To study the effect of recombinant bovine basic fibroblast growth factor(re-bFGF)on cataract patients with low endothelial cell density(ECD)after phacoemulsification and intraocular lens implantation.METHODS: Prospective study. A total of 82 patients(82 eyes)with cataract and low ECD who received phacoemulsification and intraocular lens implantation in the hospital from January 2021 to December 2023 were selected and divided into observation group(41 eyes)and control group(41 eyes)by random coin tossing method. Both groups were treated with phacoemulsification and intraocular lens implantation, and received postoperative routine treatment. The control group was administrated with recombinant human epidermal growth factor(rhEGF)eye drops(1-2 drops each time, 4 times/day)on the basis of routine treatment, while the observation group was given re-bFGF eye drops(1-2 drops each time, 4 times/day)on the basis of routine treatment, and both groups were treated continuously for 3 mo. The postoperative uncorrected visual acuity recovery, cornea-related indicators [ECD, central corneal thickness(CCT), coefficient of variation in cell area(CV), percentage of corneal endothelial hexagonal cells(HEX)], serum inflammatory factors [tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β)and interleukin-6(IL-6)before and after surgery] and complications were compared between the two groups of patients.RESULTS: There were no differences in preoperative general data between the two groups. At 1 wk, 1 and 3 mo after surgery, the visual acuity in the two groups was improved compared with that before surgery(all P<0.05). The levels of corneal ECD and HEX in the observation group at 1 wk, 1 and 3 mo after surgery were higher than those in the control group, while the levels of CCT and CV were lower than those in the control group(all P<0.05). At 3 mo after surgery, levels of TNF-α, IL-1β and IL-6 in tears were lower in the observation group compared to the control group(all P<0.05). The total incidence rate of complications in the observation group was lower than that in the control group, with no statistical significance(P>0.05).CONCLUSION: The application of re-bFGF in cataract patients with low ECD after phacoemulsification and intraocular lens implantation has good clinical value. Additionally, it can relieve the corneal injury, and reduce the burden of inflammation.
